Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes-Reference-Cited by-同舟云学术

Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes

Published:2018-05 Issue:3 Volume:4 Page:376-384
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Alves de Inda Marcia,van Strijp Dianne,den Biezen-Timmermans Eveline,van Brussel Anne,Wrobel Janneke,van Zon Hans,Vos Pieter,Baillie George S.,Tennstedt Pierre,Schlomm Thorsten,Houslay Miles D.,Bangma Chris,Hoffmann Ralf

Funder

PCMM project

Publisher

Elsevier BV

Subject

Urology

Reference26 articles.

1. Ferlay J, Soerjomataram I, Ervik M. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase. No. 11 [Internet]. Lyon, France. Int. Agency Res. Cancer 11, 2013. http://globocan.iarc.fr.

2. Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature;Lughezzani;Eur Urol,2010

3. Contemporary evaluation of the D’amico risk classification of prostate cancer;Hernandez;J Urol,2007

4. Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy;Boorjian;J Urol,2008

5. Contemporary evaluation of the National Comprehensive Cancer Network prostate cancer risk classification system;Reese;Urology,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. cAMP‐phosphodiesterase 4D7 (PDE4D7) forms a cAMP signalosome complex with DHX9 and is implicated in prostate cancer progression;Molecular Oncology;2024-01-05

2. Revisiting the roles of cAMP signalling in the progression of prostate cancer;Biochemical Journal;2023-10-13

3. Reduced PDE4D7 in prostate cancer correlates with genomic downregulation within the upstream PDE4D coding region;Future Science OA;2023-10

4. Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies;British Journal of Cancer;2023-09-22

5. Diminished PDE4D7 Expression is Associated with Treatment-Resistant, Lethal Prostate Cancer and Manifests with Impaired Androgen Response, Neuroendocrine Differentiation and Alterations in DNA Repair;2023-02-24